Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 3, 2025

Welcome, Future. Sistema endoscopico ELUXEO® 8000
RATINGEN, Germania, April 03, 2025 (GLOBE NEWSWIRE) -- Il team FUJIFILM Healthcare Europe è entusiasta di annunciare l’uscita in Europa di ELUXEO® 8000*, il nostro nuovo sistema endoscopico avanzato che include nuove capacità terapeutiche, gestione del …

Welcome, Future (Bem-vindo, futuro). Sistema de endoscopia ELUXEO® 8000
RATINGEN, Alemanha, April 03, 2025 (GLOBE NEWSWIRE) -- A equipa da FUJIFILM Healthcare Europe tem o prazer de anunciar o lançamento na Europa do ELUXEO® 8000*, o novo sistema de endoscopia avançada com novas capacidades terapêuticas, gestão do fluxo de …

Welcome, Future (Bienvenido, futuro). Sistema de endoscopia ELUXEO® 8000
RATINGEN, Alemania, April 03, 2025 (GLOBE NEWSWIRE) -- Al equipo de FUJIFILM Healthcare Europe nos complace anunciar el lanzamiento de ELUXEO 8000, nuestro nuevo sistema de endoscopia avanzado con nuevas capacidades terapéuticas, gestión del flujo de …

LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
Press release LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics Access to extensive donor pool supports LIfT’s move into the clinic London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the …

Welcome, Future. ELUXEO® 8000 Endoscopy System
RATINGEN, Germany, April 03, 2025 (GLOBE NEWSWIRE) -- The FUJIFILM Healthcare Europe Team are excited to announce the European launch of ELUXEO® 8000*, our new advanced endoscopy system with new therapeutic capabilities, workflow management and improved …

Veteran Banker Joins Avextra’s Supervisory Board
News Release Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s Supervisory Board, bringing decades of experience in corporate finance, M…

FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt
HOUSTON, April 03, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (im Folgenden kurz „FibroBiologics“), ein im klinischen Stadium tätiges Biotechnologieunternehmen mit über 240 erteilten und angemeldeten Patenten für die Entwicklung von …

FibroBiologics annonce des progrès scientifiques suite à la confirmation des résultats relatifs à la réparation de tissus cérébraux
HOUSTON, 03 avr. 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq : FBLG), ou « FibroBiologics », une société de biotechnologie au stade clinique détenant plus de 240 brevets délivrés et en instance portant sur le développement de thérapies et de …